Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1970 2
1971 2
1972 5
1973 2
1974 1
1975 2
1976 2
1977 2
1978 2
1979 4
1980 3
1981 2
1982 3
1983 4
1984 2
1985 7
1986 5
1987 4
1988 7
1989 11
1990 10
1991 8
1992 13
1993 6
1994 17
1995 9
1996 12
1997 17
1998 13
1999 17
2000 9
2001 20
2002 15
2003 15
2004 15
2005 16
2006 10
2007 19
2008 14
2009 14
2010 12
2011 28
2012 14
2013 34
2014 16
2015 29
2016 29
2017 25
2018 19
2019 21
2020 21
2021 23
2022 19
2023 20

Text availability

Article attribute

Article type

Publication date

Search Results

608 results

Results by year

Filters applied: . Clear all
Page 1
Plasma cell leukemia: A review of the molecular classification, diagnosis, and evidenced-based treatment.
Gowin K, Skerget S, Keats JJ, Mikhael J, Cowan AJ. Gowin K, et al. Leuk Res. 2021 Dec;111:106687. doi: 10.1016/j.leukres.2021.106687. Epub 2021 Aug 17. Leuk Res. 2021. PMID: 34425325 Free article. Review.
Plasma cell leukemia is a rare and aggressive plasma cell dyscrasia associated with dismal outcomes. It may arise de novo, primary plasma cell leukemia, or evolve from an antecedent diagnosis of multiple myeloma, secondary …
Plasma cell leukemia is a rare and aggressive plasma cell dyscrasia associated with dismal outcomes. It m …
Plasma Cell Leukemia: Definition, Presentation, and Treatment.
Gundesen MT, Lund T, Moeller HEH, Abildgaard N. Gundesen MT, et al. Curr Oncol Rep. 2019 Jan 28;21(1):8. doi: 10.1007/s11912-019-0754-x. Curr Oncol Rep. 2019. PMID: 30689121 Free PMC article. Review.
PURPOSE OF REVIEW: We discuss current topics on the definition of plasma cell leukemia and the distinction between plasma cell leukemia and multiple myeloma. Moreover, we review the latest literature on how to treat plasma cell …
PURPOSE OF REVIEW: We discuss current topics on the definition of plasma cell leukemia and the distinction between p …
Multiple myeloma epidemiology and survival: A unique malignancy.
Kazandjian D. Kazandjian D. Semin Oncol. 2016 Dec;43(6):676-681. doi: 10.1053/j.seminoncol.2016.11.004. Epub 2016 Nov 10. Semin Oncol. 2016. PMID: 28061985 Free PMC article. Review.
Multiple myeloma (MM), although a rare disease, is the second most common hematologic malignancy. It is found in the spectrum of plasma cell dyscrasias, which begins with monoclonal gammopathy of unknown significance (MGUS) to overt plasma cell leuk …
Multiple myeloma (MM), although a rare disease, is the second most common hematologic malignancy. It is found in the spectrum of plasma …
How we treat NK/T-cell lymphomas.
Tse E, Zhao WL, Xiong J, Kwong YL. Tse E, et al. J Hematol Oncol. 2022 Jun 3;15(1):74. doi: 10.1186/s13045-022-01293-5. J Hematol Oncol. 2022. PMID: 35659326 Free PMC article. Review.
Natural killer (NK)/T-cell lymphomas are aggressive malignancies with a predilection for Asian and South American populations. ...Therapeutic goals are to achieve undetectable plasma EBV DNA and normal PET/CT (Deauville score 3). NK/T-cell lymphomas express t …
Natural killer (NK)/T-cell lymphomas are aggressive malignancies with a predilection for Asian and South American populations. ...The …
Understanding and interpreting serum protein electrophoresis.
O'Connell TX, Horita TJ, Kasravi B. O'Connell TX, et al. Am Fam Physician. 2005 Jan 1;71(1):105-12. Am Fam Physician. 2005. PMID: 15663032 Free article. Review.
Electrophoresis separates proteins based on their physical properties, and the subsets of these proteins are used in interpreting the results. Plasma protein levels display reasonably predictable changes in response to acute inflammation, malignancy, trauma, necrosis, infa …
Electrophoresis separates proteins based on their physical properties, and the subsets of these proteins are used in interpreting the result …
Human memory B cells.
Seifert M, Küppers R. Seifert M, et al. Leukemia. 2016 Dec;30(12):2283-2292. doi: 10.1038/leu.2016.226. Epub 2016 Aug 8. Leukemia. 2016. PMID: 27499139 Review.
Thus, the human memory B-cell compartment is highly diverse and flexible. Several B-cell malignancies display features suggesting a derivation from memory B cells. This includes a subset of chronic lymphocytic leukemia, hairy cell leukemia and m …
Thus, the human memory B-cell compartment is highly diverse and flexible. Several B-cell malignancies display features suggest …
Multiple Myeloma: Molecular Pathogenesis and Disease Evolution.
Heider M, Nickel K, Högner M, Bassermann F. Heider M, et al. Oncol Res Treat. 2021;44(12):672-681. doi: 10.1159/000520312. Epub 2021 Nov 8. Oncol Res Treat. 2021. PMID: 34749378 Free PMC article. Review.
SUMMARY: The bone marrow-based disease is preceded by the 2 sequential premalignant conditions: monoclonal gammo-pathy of undetermined significance and smoldering myeloma. Plasma cell leukemia and extramedullary disease occur, when malignant clones lose their …
SUMMARY: The bone marrow-based disease is preceded by the 2 sequential premalignant conditions: monoclonal gammo-pathy of undetermined signi …
Flow cytometric immunophenotyping for hematologic neoplasms.
Craig FE, Foon KA. Craig FE, et al. Blood. 2008 Apr 15;111(8):3941-67. doi: 10.1182/blood-2007-11-120535. Epub 2008 Jan 15. Blood. 2008. PMID: 18198345 Free article. Review.
The last 10 years have seen advances in flow cytometry instrumentation and availability of an expanded range of antibodies and fluorochromes that have improved our ability to identify different normal cell populations and recognize phenotypic aberrancies, even when present …
The last 10 years have seen advances in flow cytometry instrumentation and availability of an expanded range of antibodies and fluorochromes …
European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias.
Gavriatopoulou M, Musto P, Caers J, Merlini G, Kastritis E, van de Donk N, Gay F, Hegenbart U, Hajek R, Zweegman S, Bruno B, Straka C, Dimopoulos MA, Einsele H, Boccadoro M, Sonneveld P, Engelhardt M, Terpos E. Gavriatopoulou M, et al. Leukemia. 2018 Sep;32(9):1883-1898. doi: 10.1038/s41375-018-0209-7. Epub 2018 Jul 23. Leukemia. 2018. PMID: 30038381 Free article. Review.
The introduction of novel agents in the management of multiple myeloma and related plasma cell dyscrasias has changed our treatment approaches and subsequently the outcome of patients. Due to current advances, the European Myeloma Network updated the diagnostic and …
The introduction of novel agents in the management of multiple myeloma and related plasma cell dyscrasias has changed our trea …
Richter syndrome: novel insights into the biology of transformation.
Parry EM, Ten Hacken E, Wu CJ. Parry EM, et al. Blood. 2023 Jul 6;142(1):11-22. doi: 10.1182/blood.2022016502. Blood. 2023. PMID: 36758208 Review.
Although the genetic landscape of chronic lymphocytic leukemia (CLL) has been broadly profiled by large-scale sequencing studies performed over the past decade, the molecular basis of the transformation of CLL into aggressive lymphoma, or Richter syndrome (RS), has remaine …
Although the genetic landscape of chronic lymphocytic leukemia (CLL) has been broadly profiled by large-scale sequencing studies perf …
608 results